Momenta Pharmaceuticals to Webcast Presentation at Two Upcoming Investor Conferences
May 10, 2017 12:03 pm UTC| Business
CAMBRIDGE, Mass., May 10, 2017 -- Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that it will webcast its...
UroGen Pharma Announces Closing of Initial Public Offering and Exercise of Underwriters’ Option
May 10, 2017 12:03 pm UTC| Business
RA’ANANA, Israel and NEW YORK, May 10, 2017 -- UroGen Pharma Ltd. (NASDAQ:URGN), a clinical stage biopharmaceutical company developing advanced non-surgical treatments to address unmet needs in the field of urology with...
UroGen Pharma Announces Closing of Initial Public Offering and Exercise of Underwriters’ Option
May 10, 2017 12:03 pm UTC| Business
RA’ANANA, Israel and NEW YORK, May 10, 2017 -- UroGen Pharma Ltd. (NASDAQ:URGN), a clinical stage biopharmaceutical company developing advanced non-surgical treatments to address unmet needs in the field of urology with...
UroGen Pharma Announces Closing of Initial Public Offering and Exercise of Underwriters’ Option
May 10, 2017 12:03 pm UTC| Business
RA’ANANA, Israel and NEW YORK, May 10, 2017 -- UroGen Pharma Ltd. (NASDAQ:URGN), a clinical stage biopharmaceutical company developing advanced non-surgical treatments to address unmet needs in the field of urology with...
May 10, 2017 12:03 pm UTC| Business
PLYMOUTH MEETING, Pa., May 10, 2017 -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today announced MedImmune, AstraZeneca’s global biologics research and development arm, will start a new clinical trial investigating the...
Dimension Therapeutics Reports First Quarter 2017 Financial Results and Provides Corporate Update
May 10, 2017 12:03 pm UTC| Business
Discontinues Clinical Development of DTX101, an AAVrh10 Factor IX Gene Therapy Product Candidate for Moderate/Severe-to-Severe Hemophilia B Initial data from Phase 1/2 clinical trial of DTX301, Dimension’s lead AAV8...
KEMET Reports Preliminary Fourth Quarter and Fiscal Year 2017 Results
May 10, 2017 12:03 pm UTC| Business
Net sales for the quarter up 5.0% to $197.5 million compared to the prior quarter ended December31, 2016Gross margin for fiscal year 2017 of 24.6% compared to 22.2% for the prior fiscal year 2016Cash Balance at March31,...